PT - JOURNAL ARTICLE AU - Getzen, Emily AU - Tan, Amelia LM AU - Brat, Gabriel AU - Omenn, Gilbert S. AU - Strasser, Zachary AU - , AU - Long, Qi AU - Holmes, John H. AU - Mowery, Danielle TI - Leveraging informative missing data to learn about acute respiratory distress syndrome and mortality in long-term hospitalized COVID-19 patients throughout the years of the pandemic AID - 10.1101/2023.12.18.23300181 DP - 2023 Jan 01 TA - medRxiv PG - 2023.12.18.23300181 4099 - http://medrxiv.org/content/early/2023/12/19/2023.12.18.23300181.short 4100 - http://medrxiv.org/content/early/2023/12/19/2023.12.18.23300181.full AB - Electronic health records (EHRs) contain a wealth of information that can be used to further precision health. One particular data element in EHRs that is not only under-utilized but oftentimes unaccounted for is missing data. However, missingness can provide valuable information about comorbidities and best practices for monitoring patients, which could save lives and reduce burden on the healthcare system. We characterize patterns of missing data in laboratory measurements collected at the University of Pennsylvania Hospital System from long-term COVID-19 patients and focus on the changes in these patterns between 2020 and 2021. We investigate how these patterns are associated with comorbidities such as acute respiratory distress syndrome (ARDS), and 90-day mortality in ARDS patients. This work displays how knowledge and experience can change the way clinicians and hospitals manage a novel disease. It can also provide insight into best practices when it comes to patient monitoring to improve outcomes.Competing Interest StatementThe authors have declared no competing interest.Funding StatementGSO is supported by NIH grants U24CA210967 and P30ES017885. EG and QL are supported by NIGMS R01GM124111 and NIA RF1AG063481. DLM and JHH are supported by NCATS UL1-TR001878 and U24-DK133700.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:IRB Approval was obtained at Assistance Publique Hopitaux de Paris, Beth Israel Deaconess Medical Center, Bordeaux University Hospital, Hospital Universitario 12 de Octubre, Massachusetts General Brigham, Northwestern University, Medical Center, University of Freiburg, University of Pittsburgh, VA North Atlantic, VA Southwest, VA Midwest, VA Continental, and VA Pacific. An exempt determination was made by the IRB at University of California Los Angeles, University of Michigan, and University of Pennsylvania.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesOnly aggregate data was shared by sites for this study. All aggregate data in a de-identified fashion can be found and downloaded at www.covidclinical.net.https://www.covidclinical.net